This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 79 words of the full text and any section headings.

To the Editor: The article by Thompson et al¹ provides information highlighting a common clinical problem. The article's discussion on management did not explore any alternatives to creatine kinase (CK) measurement. Are the authors aware of any data or, in their clinical experience, have they found any other noninvasive testing, such as measurement of serum aldolase level, that assists in managing cases of statin-associated myopathy?

Dr Hyman published a similar letter in Ann Intern Med. 2002;138:1007.—ED.

Mark H. Hyman, MD
Department of Medicine
University of California, Los Angeles

1. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289:1681-1690. FREE FULL TEXT

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290:888.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Issues in Statin-Associated Myopathy
Join Y. Luh and Bernard M. Karnath
JAMA. 2003;290(7):888.
EXTRACT | FULL TEXT  

Issues in Statin-Associated Myopathy—Reply
Paul D. Thompson, Priscilla Clarkson, and Richard H. Karas
JAMA. 2003;290(7):888-889.
EXTRACT | FULL TEXT  

Statin-Associated Myopathy
Paul D. Thompson, Priscilla Clarkson, and Richard H. Karas
JAMA. 2003;289(13):1681-1690.
ABSTRACT | FULL TEXT